Get startedLog in
    Picture of Organigram Global logo

    OGI — Organigram Global Income Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapTurnaround
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Organigram Global, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.

    2020
    August 31st
    2021
    August 31st
    2022
    August 31st
    2023
    September 30th
    2024
    September 30th
    Period Length:12 M12 M12 M13 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue86.879.2146162160
    Cost of Revenue
    Gross Profit-12.1-24.4-8.43-31-3.63
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Total Operating Expenses227169188424196
    Operating Profit-141-89.7-42.7-263-35.7
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-147-131-14.4-252-45.4
    Provision for Income Taxes
    Net Income After Taxes-136-131-14.3-249-45.4
    Net Income Before Extraordinary Items
    Extraordinary Items
    Net Income-136-131-14.3-249-45.4
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-136-131-14.3-249-45.4
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-1.96-1.81-0.434-1.93-1.02
    Dividends per Share